Identifier,Name,Reference,Description,IUPAC Name,CAS,Formula,SMILES,INCHI,INCHI key,
CHENDI00001,iproclozide,pmid:26751493,"Iproclozide is an irreversible and selective monoamine oxidase inhibitor (MAOI) of the hydrazine chemical class that was used as an antidepressant, but has since been discontinued. It has been known to cause fulminant hepatitis and there have been at least three reported fatalities due to administration of the drug.",2-(4-chlorophenoxy)-N-propan-2-ylacetohydrazide,3544-35-2,C11H15ClN2O2,CC(C)NNC(=O)COC1=CC=C(C=C1)Cl,"InChI=1S/C11H15ClN2O2/c1-8(2)13-14-11(15)7-16-10-5-3-9(12)4-6-10/h3-6,8,13H,7H2,1-2H3,(H,14,15)",GGECDTUJZOXAAR-UHFFFAOYSA-N,
CHENDI00002,Iproniazid,pmid:26751493,"A non-selective, irreversible monoamine oxidase inhibitor (MAOI) of the hydrazine class. It is a xenobiotic that was originally designed to treat tuberculosis, but was later most prominently used as an antidepressant drug. However, it was withdrawn from the market because of its hepatotoxicity. (Wikipedia). Withdrawn from the Canadian market in July 1964 due to interactions with food products containing tyrosine. (DRUGBANK)",N-propan-2-ylpyridine-4-carbohydrazide,54-92-2,C9H13N3O,CC(C)NNC(=O)C1=CC=NC=C1,"InChI=1S/C9H13N3O/c1-7(2)11-12-9(13)8-3-5-10-6-4-8/h3-7,11H,1-2H3,(H,12,13)",NYMGNSNKLVNMIA-UHFFFAOYSA-N,
CHENDI00003,isocarboxazide,pmid:26751493,"A non-selective, irreversible monoamine oxidase inhibitor (MAOI) of the hydrazine class, used in the treatment of major depression, dysthymic disorder, atypical disorder, panic disorder and the phobic disorders. Inhibitor of tau aggregation","N-benzyl-5-methyl-1,2-oxazole-3-carbohydrazide",59-63-2,C12H13N3O2,CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2,"InChI=1S/C12H13N3O2/c1-9-7-11(15-17-9)12(16)14-13-8-10-5-3-2-4-6-10/h2-7,13H,8H2,1H3,(H,14,16)",XKFPYPQQHFEXRZ-UHFFFAOYSA-N,
CHENDI00004,isoniazid,pmid:26751493,Inhibitor of tau aggregation,pyridine-4-carbohydrazide,54-85-3,C6H7N3O,C1=CN=CC=C1C(=O)NN,"InChI=1S/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,7H2,(H,9,10)",QRXWMOHMRWLFEY-UHFFFAOYSA-N,
CHENDI00005,oxazolidinedione,pmid:26751493,Inhibitor of tau aggregation,"1,3-oxazolidine-2,4-dione",2346-26-1,C3H3NO3,C1C(=O)NC(=O)O1,"InChI=1S/C3H3NO3/c5-2-1-7-3(6)4-2/h1H2,(H,4,5,6)",COWNFYYYZFRNOY-UHFFFAOYSA-N,
CHENDI00006,sudoxicam,pmid:26751493,Inhibitor of tau aggregation,"4-hydroxy-2-methyl-1,1-dioxo-N-(1,3-thiazol-2-yl)-1$l^{6},2-benzothiazine-3-carboxamide",34042-85-8,C13H11N3O4S2,CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=NC=CS3,"InChI=1S/C13H11N3O4S2/c1-16-10(12(18)15-13-14-6-7-21-13)11(17)8-4-2-3-5-9(8)22(16,19)20/h2-7,17H,1H3,(H,14,15,18)",SYCHUQUJURZQMO-UHFFFAOYSA-N,
CHENDI00007,thiohydantoin,pmid:26751493,Inhibitor of tau aggregation,2-sulfanylideneimidazolidin-4-one,503-87-7,C3H4N2OS,C1C(=O)NC(=S)N1,"InChI=1S/C3H4N2OS/c6-2-1-4-3(7)5-2/h1H2,(H2,4,5,6,7)",UGWULZWUXSCWPX-UHFFFAOYSA-N,
CHENDI00008,thioxooxazolidine,pmid:26751493,Inhibitor of tau aggregation,,,,,,,
CHENDI00009,(-)-epicatechin,pmid:23531502,Reduces tangle formation by inhibiting the oxidative effects of hydrogen peroxide,"(2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol",490-46-0,C15H14O6,[H][C@@]1(Oc2cc(O)cc(O)c2C[C@H]1O)c1ccc(O)c(O)c1,"InChI=1S/C15H14O6/c16-8-4-11(18)9-6-13(20)15(21-14(9)5-8)7-1-2-10(17)12(19)3-7/h1-5,13,15-20H,6H2/t13-,15-/m1/s1", PFTAWBLQPZVEMU-UKRRQHHQSA-N,
CHENDI00010,cinnamaldehyde,pmid:23531502,Prevents the formation of tau aggregates induced by hydrogen peroxide acitvity through interferring with the latters oxidative effect,(3E)-3-phenylprop-2-ena,14371-10-9,C9H8O,O=C\C=C\c1ccccc1,InChI=1S/C9H8O/c10-8-4-7-9-5-2-1-3-6-9/h1-8H/b7-4+,KJPRLNWUNMBNBZ-QPJJXVBHSA-N,
CHENDI00011,daunorubicin,pmid:26751493,Inhibitor of tau aggregation,"(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside",20830-81-3,C27H29NO10,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(C)=O,"InChI=1S/C27H29NO10/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33/h4-6,10,14,16-17,22,30,32,34-35H,7-9,28H2,1-3H3/t10-,14-,16-,17-,22+,27-/m0/s1",STQGQHZAVUOBTE-VGBVRHCVSA-N,
CHENDI00012,doxorubicin,pmid:26751493,Inhibitor of tau aggregation,"(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside",23214-92-8,C27H29NO11,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO,"InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1",AOJJSUZBOXZQNB-TZSSRYMLSA-N,
CHENDI00013,emodin,pmid:26751493,Inhibitor of tau aggregation,"1,3,8-trihydroxy-6-methylanthra-9,10-quinone",518-82-1,C15H10O5,Cc1cc(O)c2C(=O)c3c(O)cc(O)cc3C(=O)c2c1,"InChI=1S/C15H10O5/c1-6-2-8-12(10(17)3-6)15(20)13-9(14(8)19)4-7(16)5-11(13)18/h2-5,16-18H,1H3",RHMXXJGYXNZAPX-UHFFFAOYSA-N,
CHENDI00014,methylene blue,pmid:26751493,A phenotiazine able to cross the BBB and act as a redox cycler. Reduces tau aggregation and decreases Caspase levels,"3,7-bis(dimethylamino)phenothiazin-5-ium chloride",61-73-4,C16H18N3SCl,[Cl-].CN(C)c1ccc2nc3ccc(cc3[s+]c2c1)N(C)C,"InChI=1S/C16H18N3S.ClH/c1-18(2)11-5-7-13-15(9-11)20-16-10-12(19(3)4)6-8-14(16)17-13;/h5-10H,1-4H3;1H/q+1;/p-1",CXKWCBBOMKCUKX-UHFFFAOYSA-M,
CHENDI00015,myricetin,pmid:26751493,Inhibitor of tau aggregation,"3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one",529-44-2,C15H10O8,Oc1cc(O)c2c(c1)oc(-c1cc(O)c(O)c(O)c1)c(O)c2=O,"InChI=1S/C15H10O8/c16-6-3-7(17)11-10(4-6)23-15(14(22)13(11)21)5-1-8(18)12(20)9(19)2-5/h1-4,16-20,22H",IKMDFBPHZNJCSN-UHFFFAOYSA-N,
CHENDI00016,quinalizarin,pmid:26751493,Inhibitor of tau aggregation,"1,2,5,8-tetrahydroxyanthracene-9,10-dione",81-61-8,C14H8O6,Oc1ccc2C(=O)c3c(O)ccc(O)c3C(=O)c2c1O,"InChI=1S/C14H8O6/c15-6-3-4-7(16)11-10(6)12(18)5-1-2-8(17)13(19)9(5)14(11)20/h1-4,15-17,19H",VBHKTXLEJZIDJF-UHFFFAOYSA-N,
CHENDI00017,rhodanine,pmid:26751493,Inhibitor of tau aggregation,"2-sulfanylidene-1,3-thiazolidin-4-one",141-84-4,C3H3NOS2,O=C1CSC(=S)N1,"InChI=1S/C3H3NOS2/c5-2-1-7-3(6)4-2/h1H2,(H,4,5,6)",KIWUVOGUEXMXSV-UHFFFAOYSA-N,
CHENDI00018,thiostrepton,pmid:26751493,Inhibitor of tau aggregation,,1393-48-2,C72H85N19O18S5,[H][C@]12N=C(CC[C@@]11NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC(=O)[C@@H](N[C@@H]3C=Cc4c(cc(nc4[C@H]3O)C(=O)O[C@H](C)[C@H](NC(=O)c3csc(n3)[C@@H](NC(=O)[C@H]3CSC(=N3)\C(NC(=O)[C@@H](NC(=O)c3csc1n3)[C@@H](C)O)=C\C)[C@](C)(O)[C@@H](C)O)c1nc2cs1)[C@H](C)O)[C@@H](C)CC)c1nc(cs1)C(=O)NC(=C)C(=O)NC(=C)C(N)=O,"InChI=1S/C72H85N19O18S5/c1-14-26(3)47-63(105)78-30(7)57(99)75-28(5)56(98)76-31(8)58(100)91-72-19-18-40(66-85-43(22-111-66)59(101)77-29(6)55(97)74-27(4)54(73)96)81-52(72)42-21-112-67(83-42)49(34(11)109-69(107)41-20-37(32(9)92)36-16-17-39(79-47)51(95)50(36)80-41)89-60(102)44-24-113-68(86-44)53(71(13,108)35(12)94)90-62(104)45-23-110-65(84-45)38(15-2)82-64(106)48(33(10)93)88-61(103)46-25-114-70(72)87-46/h15-17,20-22,24-26,30-35,39,45,47-49,51-53,79,92-95,108H,4-6,14,18-19,23H2,1-3,7-13H3,(H2,73,96)(H,74,97)(H,75,99)(H,76,98)(H,77,101)(H,78,105)(H,82,106)(H,88,103)(H,89,102)(H,90,104)(H,91,100)/b38-15-/t26-,30-,31-,32-,33+,34+,35+,39+,45+,47-,48-,49-,51-,52+,53+,71+,72+/m0/s1",NSFFHOGKXHRQEW-AIHSUZKVSA-N,
CHENDI00019,LDN-193594,"pmid:23737518, pmid:21353545",Inhibitor of GSK3B and CDK5 activity,,,,,,,
CHENDI00020,LDN-193665,"pmid:23737518, pmid:21353545",Inhibitor of GSK3B and CDK5 activity,,,,,,,
CHENDI00021,LDN-213843,pmid:23737518,Inhibitor of GSK3B and CDK5 activity,,,,,,,
CHENDI00022,indirubin,pmid:11013232,A powerful inhibitor of GSK3B,"(3Z)-3-(3-Oxo-1,3-dihydro-2H-indol-2-ylidene)-1,3-dihydro-2H-indol-2-one",479-41-4,C16H10N2O2,C1=CC=C2C(=C1)C(=C3C(=O)C4=CC=CC=C4N3)C(=O)N2,"InChI=1S/C16H10N2O2/c19-15-10-6-2-4-8-12(10)17-14(15)13-9-5-1-3-7-11(9)18-16(13)20/h1-8,17H,(H,18,20)/b14-13-",CRDNMYFJWFXOCH-YPKPFQOOSA-N,
CHENDI00023,isopentanyladenine,pmid:8726973,Inhibitor of CKD5 activity,N-(3-methylbut-2-enyl)-7H-purin-6-amine,2365-40-4,C10H13N5,CC(=CCNC1=NC=NC2=C1NC=N2)C,"InChI=1S/C10H13N5/c1-7(2)3-4-11-9-8-10(13-5-12-8)15-6-14-9/h3,5-6H,4H2,1-2H3,(H2,11,12,13,14,15)",HYVABZIGRDEKCD-UHFFFAOYSA-N,
CHENDI00024,olomoucine,pmid:8726973,Inhibitor of CKD5 activity,2-[[6-(benzylamino)-9-methylpurin-2-yl]amino]ethanol,101622-51-9,C15H18N6O,CN1C=NC2=C1N=C(N=C2NCC3=CC=CC=C3)NCCO,"InChI=1S/C15H18N6O/c1-21-10-18-12-13(17-9-11-5-3-2-4-6-11)19-15(16-7-8-22)20-14(12)21/h2-6,10,22H,7-9H2,1H3,(H2,16,17,19,20)",GTVPOLSIJWJJNY-UHFFFAOYSA-N,
CHENDI00025,tideglusib,pmid:22102280,Irreversibly inhibits GSK3B activity,"4-benzyl-2-naphthalen-1-yl-1,2,4-thiadiazolidine-3,5-dione",,C19H14N2O2S,C1=CC=C(C=C1)CN2C(=O)N(SC2=O)C3=CC=CC4=CC=CC=C43,"InChI=1S/C19H14N2O2S/c22-18-20(13-14-7-2-1-3-8-14)19(23)24-21(18)17-12-6-10-15-9-4-5-11-16(15)17/h1-12H,13H2",PMJIHLSCWIDGMD-UHFFFAOYSA-N,
CHENDI00026,BAY61-3606,pmid:26501932,A potent and selective inhibitor of Syk kinase with an indirect inhibitory effect on GSK3B activity,"3-Pyridinecarboxamide, 2-[[7-(3,4-dimethoxyphenyl)imidazo[1,2-c]pyrimidin-5-yl]amino]-, hydrochloride (1:2)",	648903-57-5,C20H18N6O3.2HCl,O=C(C1=CC=CN=C1NC2=NC(C3=CC=C(OC)C(OC)=C3)=CC4=NC=CN24)N,,,
CHENDI00027,(-)-epigallocatechin 3-gallate,pmid:28775333,"Green tea flavonol acts as DYRK1A inhibitor and reduces the presence 3R Tau isoforms, relieving anxiety and positively affecting memory","(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate",989-51-5,C22H18O11,Oc1cc(O)c2C[C@@H](OC(=O)c3cc(O)c(O)c(O)c3)[C@H](Oc2c1)c1cc(O)c(O)c(O)c1,"InChI=1S/C22H18O11/c23-10-5-12(24)11-7-18(33-22(31)9-3-15(27)20(30)16(28)4-9)21(32-17(11)6-10)8-1-13(25)19(29)14(26)2-8/h1-6,18,21,23-30H,7H2/t18-,21-/m1/s1",WMBWREPUVVBILR-WIYYLYMNSA-N,
CHENDI00028,Phenylglyoxal,pmid:7514173,Inhibitor of GSK3B activity,2-oxo-2-phenylacetaldehyde,1074-12-0,C8H6O2,C1=CC=C(C=C1)C(C=O)=O,InChI=1S/C8H6O2/c9-6-8(10)7-4-2-1-3-5-7/h1-6H,OJUGVDODNPJEEC-UHFFFAOYSA-N,
CHENDI00029,all-trans-retinoic acid,pmid:26400044,Shown to inhibit CDK5 and GSK3B activity in mice and conseguently attenuate the formation of hyperphosphorylated tau. Prevents accumulation of amyloid plaques,"(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid",302-79-4,C20H28O2,CC(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(C)=C/C(O)=O,"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+",SHGAZHPCJJPHSC-YCNIQYBTSA-N,
CHENDI00030,alsterpaullone,"pmid:10998059, pmid:22102280","Inhibitor of GSK3B and CDK5 activity, decreases tau phosphorylation","9-nitro-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one",237430-03-4	,C16H11N3O3,C12=CC=C(C=C2C=3CC(NC4=CC=CC=C4C3N1)=O)[N+](=O)[O-],"InChI=1S/C16H11N3O3/c20-15-8-12-11-7-9(19(21)22)5-6-14(11)18-16(12)10-3-1-2-4-13(10)17-15/h1-7,18H,8H2,(H,17,20)",OLUKILHGKRVDCT-UHFFFAOYSA-N,
CHENDI00031,calcium dichloride,pmid:7514173,Inhibitor of GSK3B acitvity,calcium chloride,10043-52-4,CaCl2,[Cl-].[Cl-].[Ca++],InChI=1S/Ca.2ClH/h;2*1H/q+2;;/p-2,UXVMQQNJUSDDNG-UHFFFAOYSA-L,
CHENDI00032,diethyl pyrocarbonate,pmid:7514173,Inhibitor of GSK3B activity,diethyl dicarbonate,1609-47-8,C6H10O5,CCOC(=O)OC(=O)OCC,"InChI=1S/C6H10O5/c1-3-9-5(7)11-6(8)10-4-2/h3-4H2,1-2H3",FFYPMLJYZAEMQB-UHFFFAOYSA-N,
CHENDI00033,glycerol 2-phosphate,pmid:7514173,Inhibitor of GSK3B activity,glycerol 2-(dihydrogen phosphate),17181-54-3,C3H9O6P,OCC(CO)OP(O)(O)=O,"InChI=1S/C3H9O6P/c4-1-3(2-5)9-10(6,7)8/h3-5H,1-2H2,(H2,6,7,8)",DHCLVCXQIBBOPH-UHFFFAOYSA-N,
CHENDI00034,harmine,pmid:28250274,Upregulates Neprilysin (MME) through the inhibition of DYRK1A,"7-methoxy-1-methyl-9H-pyrido[3,4-b]indole",442-51-3,C13H12N2O,CC1=NC=CC2=C1NC3=C2C=CC(=C3)OC,"InChI=1S/C13H12N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-7,15H,1-2H3",BXNJHAXVSOCGBA-UHFFFAOYSA-N,
CHENDI00035,hypothemycin,pmid:22102280,Inhibitor of GSK3B activity,"(1aR,8S,10Z,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione",,C19H22O8,COc1cc(O)c2c(c1)[C@H]1O[C@@H]1C[C@H](O)[C@H](O)C(=O)\C=C/C[C@H](C)OC2=O,"InChI=1S/C19H22O8/c1-9-4-3-5-12(20)17(23)14(22)8-15-18(27-15)11-6-10(25-2)7-13(21)16(11)19(24)26-9/h3,5-7,9,14-15,17-18,21-23H,4,8H2,1-2H3/b5-3-/t9-,14-,15+,17+,18+/m0/s1",SSNQAUBBJYCSMY-KNTMUCJRSA-N,
CHENDI00036,manganese(II) chloride,pmid:7514173,Inhibitor of GSK3B activity,manganese(2+) dichloride,7773-01-05,Cl2Mn,Cl[Mn]Cl,InChI=1S/2ClH.Mn/h2*1H;/q;;+2/p-2,GLFNIEUTAYBVOC-UHFFFAOYSA-L,
CHENDI00037,poly(lysine) polymer,pmid:7514173,Inhibitor of GSK3B activity,,,,,,,
CHENDI00038,pyridoxal 5-phosphate,pmid:7514173,Inhibitor of GSK3B activity,(4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl dihydrogen phosphate,54-47-7,C8H10NO6P,[H]C(=O)c1c(COP(O)(O)=O)cnc(C)c1O,"InChI=1S/C8H10NO6P/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14/h2-3,11H,4H2,1H3,(H2,12,13,14)",NGVDGCNFYWLIFO-UHFFFAOYSA-N,
CHENDI00039,sodium chloride,pmid:7514173,Inhibitor of GSK3B activity,sodium chloride,7647-14-5,ClNa,[Na+].[Cl-],InChI=1S/ClH.Na/h1H;/q;+1/p-1,FAPWRFPIFSIZLT-UHFFFAOYSA-M,
CHENDI00040,sodium fluoride,pmid:7514173,Inhibitor of GSK3B activity,sodium fluoride,7681-49-4,FNa,[F-].[Na+],InChI=1S/FH.Na/h1H;/q;+1/p-1,PUZPDOWCWNUUKD-UHFFFAOYSA-M,
CHENDI00041,staurosporine,"pmid:23001711, pmid:8726973",Inhibitor of CDK5 and MARK kinase activity. Reduces tau phosphorylation at Ser262,"(5S,6R,7R,9R)-6-methoxy-5-methyl-7-methylamino-6,7,8,9,15,16-hexahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-14-one",62996-74-1,C28H26N4O3,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13,"InChI=1S/C28H26N4O3/c1-28-26(34-3)17(29-2)12-20(35-28)31-18-10-6-4-8-14(18)22-23-16(13-30-27(23)33)21-15-9-5-7-11-19(15)32(28)25(21)24(22)31/h4-11,17,20,26,29H,12-13H2,1-3H3,(H,30,33)/t17-,20-,26-,28+/m1/s1",HKSZLNNOFSGOKW-FYTWVXJKSA-N,
CHENDI00042,ID-8,pmid:28884684,ID-8 is an indole derivative (Miyabayashi et al.) that inhibits members of the dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) family. ,1-(4-methoxyphenyl)-2-methyl-3-nitro-1H-indol-6-ol,147591-46-6,C16H14N2O4,OC1=CC2=C(C=C1)C([N+]([O-])=O)=C(C)N2C3=CC=C(OC)C=C3,"InChI=1S/C16H14N2O4/c1-10-16(18(20)21)14-8-5-12(19)9-15(14)17(10)11-3-6-13(22-2)7-4-11/h3-9,19H,1-2H3",VVZNWYXIOADGSW-UHFFFAOYSA-N,
CHENDI00043,tanespimycin,pmid:21367866,"A 19-membered macrocyle that is geldanamycin in which the methoxy substituent attached to the benzoquinone moiety has been replaced by an allylamino group. It is a potent inhibitor of heat shock protein 90 (Hsp90). A less toxic analogue than geldanamycin, it induces apoptosis and displays antitumour effects. Shown to reduce tau levels through the inhibition of Hsp90","(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate",75747-14-7,C31H43N3O8,C=1C(C(=C2C(C1NC(=O)C(C)=CC=C[C@@H]([C@@H](OC(N)=O)C(C)=C[C@@H]([C@H]([C@H](C[C@@H](C2)C)OC)O)C)OC)=O)NCC=C)=O,"InChI=1S/C31H43N3O8/c1-8-12-33-26-21-13-17(2)14-25(41-7)27(36)19(4)15-20(5)29(42-31(32)39)24(40-6)11-9-10-18(3)30(38)34-22(28(21)37)16-23(26)35/h8-11,15-17,19,24-25,27,29,33,36H,1,12-14H2,2-7H3,(H2,32,39)(H,34,38)/b11-9-,18-10+,20-15+/t17-,19+,24+,25+,27-,29+/m1/s1",AYUNIORJHRXIBJ-TXHRRWQRSA-N,17-AAG
CHENDI00044,SL-327,pmid:24401760,"A MEK1/2 inhibitor, shown to inhibit the production of amyloid-beta peptides in a mouse neuroblastoma cell line.",(Z)-3-amino-3-(4-aminophenyl)sulfanyl-2-[2-(trifluoromethyl)phenyl]prop-2-enenitrile,305350-87-2,C16H12F3N3S,C1=CC=C(C(=C1)C(=C(N)SC2=CC=C(C=C2)N)C#N)C(F)(F)F,"InChI=1S/C16H12F3N3S/c17-16(18,19)14-4-2-1-3-12(14)13(9-20)15(22)23-11-7-5-10(21)6-8-11/h1-8H,21-22H2/b15-13+",JLOXTZFYJNCPIS-FYWRMAATSA-N,
CHENDI00045,Thiamet G,pmid:22833681,Thiamet G is a potent and selective inhibitor of O-GlcNAcase that demonstrates a Ki value of 21 nM. It increases cellular O-GlcNAc-modified protein levels (EC50 = 30 nM) and blocks phosphorylation of tau protein both in cultured PC-12 cells and in rats (200 mg/kg/day).2 Thiamet G is the first highly potent O-GlcNAcase inhibitor known to be orally bioavailable and effectively cross the blood brain barrier,"2-(ethylamino)-3aR,6S,7R,7aR-tetrahydro-5R-(hydroxymethyl)-5H-pyrano[3,2-d]thiazole-6,7-diol",1009816-48-1,C9H16N2O4S,[H][C@@]12[C@@](N=C(N(CC)[H])S2)([H])[C@@H](O)[C@H](O)[C@@H](CO)O1,"InChI=1S/C9H16N2O4S/c1-2-10-9-11-5-7(14)6(13)4(3-12)15-8(5)16-9/h4-8,12-14H,2-3H2,1H3,(H,10,11)/t4-,5-,6-,7-,8-/m1/s1",PPAIMZHKIXDJRN-FMDGEEDCSA-N,
CHENDI00046,L-ascorbic acid,pmid:23722080,In a mixture with Trolox and gluthatione was shown to reduce tau phosphorylation at PHF1 epitope,"(5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one",50-81-7,C6H8O6,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,"InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/t2-,5+/m0/s1",CIWBSHSKHKDKBQ-JLAZNSOCSA-N,
CHENDI00047,Nilvadipine,pmid:25331948,"A L-type calcium channel antagonist, it reduces brain amyloid beta accumulation in the brain and also reduces tau phosphorylation at the PHF1 and AT8 epitopes","3-Methyl 5-propan-2-yl 2-cyano-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate",75530-68-6,C19H19N3O6,CC1=C(C(C(=C(N1)C#N)C(=O)OC)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC(C)C,"InChI=1S/C19H19N3O6/c1-10(2)28-19(24)15-11(3)21-14(9-20)17(18(23)27-4)16(15)12-6-5-7-13(8-12)22(25)26/h5-8,10,16,21H,1-4H3",FAIIFDPAEUKBEP-UHFFFAOYSA-N,
CHENDI00048,dimethyl fumarate,pmid:29121589,"Inhibitor of ERK, p38 and AKT activity. Induces a deactivating phosphorylation on GSK3B and decreases tau phosphorylation. Reduced microgliosis and astrogliosis",dimethyl (2E)-but-2-enedioate,624-49-7,C6H8O4,COC(=O)\C=C\C(=O)OC,"InChI=1S/C6H8O4/c1-9-5(7)3-4-6(8)10-2/h3-4H,1-2H3/b4-3+",LDCRTTXIJACKKU-ONEGZZNKSA-N,
CHENDI00049,homocysteine,pmid:28632203,Biomarker for AD,2-amino-4-sulfanylbutanoic acid,,C4H9NO2S,NC(CCS)C(O)=O,"InChI=1S/C4H9NO2S/c5-3(1-2-8)4(6)7/h3,8H,1-2,5H2,(H,6,7)",FFFHZYDWPBMWHY-UHFFFAOYSA-N,
CHENDI00050,memantine,pmid:23722080,"Anti-AD drug, prevents tau phosphorylation","3,5-dimethyladamantan-1-amine",19982-08-02,C12H21N,CC12CC3CC(C)(C1)CC(N)(C3)C2,"InChI=1S/C12H21N/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10/h9H,3-8,13H2,1-2H3",BUGYDGFZZOZRHP-UHFFFAOYSA-N,
CHENDI00051,paclitaxel,pmid:22941973,Reduces tau phosphorylation at Ser262,"4α,10β-bis(acetyloxy)-13α-[(2S,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyloxy]-1,7β-dihydroxy-9-oxo-5β,20-epoxytax-11-en-2α-yl benzoate",33069-62-4,C47H51NO14,[H][C@]12[C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,"InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1",RCINICONZNJXQF-MZXODVADSA-N,
CHENDI00052,sirolimus,pmid:26751493,Induces macroautophagy which indirectly inhibits tau,"(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone",53123-88-9,C51H79NO13,[H][C@]1(CC[C@@H](O)[C@@H](C1)OC)C[C@@H](C)[C@]1([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]2([H])CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC,"InChI=1S/C51H79NO13/c1-30-16-12-11-13-17-31(2)42(61-8)28-38-21-19-36(7)51(60,65-38)48(57)49(58)52-23-15-14-18-39(52)50(59)64-43(33(4)26-37-20-22-40(53)44(27-37)62-9)29-41(54)32(3)25-35(6)46(56)47(63-10)45(55)34(5)24-30/h11-13,16-17,25,30,32-34,36-40,42-44,46-47,53,56,60H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12+,31-17+,35-25+/t30-,32-,33-,34-,36-,37+,38+,39+,40-,42+,43+,44-,46-,47+,51-/m1/s1",QFJCIRLUMZQUOT-HPLJOQBZSA-N,
CHENDI00053,trans-5-O-caffeoyl-D-quinic acid,pmid:26751493,A cinnamate ester obtained by formal condensation of the carboxy group of trans-caffeic acid with the 5-hydroxy group of quinic acid. Inhibitor of protein phosphatase methylesterase (PME) improved cognition and motor performance in mice,"1D-[1(OH),3,4/5]-3-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyloxy]-1,4,5-trihydroxycyclohexanecarboxylic acid",202650-88-2,C16H18O9,[H][C@]1(O)[C@H](O)C[C@@](O)(C[C@H]1OC(=O)\C=C\c1ccc(O)c(O)c1)C(O)=O,"InChI=1S/C16H18O9/c17-9-3-1-8(5-10(9)18)2-4-13(20)25-12-7-16(24,15(22)23)6-11(19)14(12)21/h1-5,11-12,14,17-19,21,24H,6-7H2,(H,22,23)/b4-2+/t11-,12-,14+,16-/m1/s1",CWVRJTMFETXNAD-NXLLHMKUSA-N,
CHENDI00054,Tubacin,pmid:23487739,"Tubacin (tubulin acetylation inducer) is a highly potent and selective, reversible, cell-permeable inhibitor of HDAC6 (IC50=0.004µM). IC50's for the other HDACs are 1000-fold higher, making tubacin both more selective and more potent than Tubastatin A, which also inhibits HDAC8. Concentration in cell culture experiments typically ranges from 2-50µM.","N-[4-[(2R,4R,6S)-4-[(4,5-diphenyl-1,3-oxazol-2-yl)sulfanylmethyl]-6-[4-(hydroxymethyl)phenyl]-1,3-dioxan-2-yl]phenyl]-N'-hydroxyoctanediamide",537049-40-4,C41H43N3O7S,C1C(OC(OC1C2=CC=C(C=C2)CO)C3=CC=C(C=C3)NC(=O)CCCCCCC(=O)NO)CSC4=NC(=C(O4)C5=CC=CC=C5)C6=CC=CC=C6,"InChI=1S/C41H43N3O7S/c45-26-28-17-19-29(20-18-28)35-25-34(27-52-41-43-38(30-11-5-3-6-12-30)39(51-41)31-13-7-4-8-14-31)49-40(50-35)32-21-23-33(24-22-32)42-36(46)15-9-1-2-10-16-37(47)44-48/h3-8,11-14,17-24,34-35,40,45,48H,1-2,9-10,15-16,25-27H2,(H,42,46)(H,44,47)/t34-,35+,40+/m1/s1",BHUZLJOUHMBZQY-YXQOSMAKSA-N,
CHENDI00055,Trolox,pmid:23722080,"water soluble vit. E-analog, inhibits tau phosphorylation at Ser262 and Ser404","6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid",53188-07-01,C14H18O4,Cc1c(C)c2OC(C)(CCc2c(C)c1O)C(O)=O,"InChI=1S/C14H18O4/c1-7-8(2)12-10(9(3)11(7)15)5-6-14(4,18-12)13(16)17/h15H,5-6H2,1-4H3,(H,16,17)",GLEVLJDDWXEYCO-UHFFFAOYSA-N,
CHENDI00056,rolipram,pmid:26692334,"Phosphodiesterase inhibitor, induces proteasomal activity and decreases tau aggregation.",4-[3-(cyclopentyloxy)-4-methoxyphenyl]pyrrolidin-2-one,61413-54-5,C16H21NO3,COc1ccc(cc1OC1CCCC1)C1CNC(=O)C1,"InChI=1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18)",HJORMJIFDVBMOB-UHFFFAOYSA-N,
CHENDI00057,salsalate,pmid:26390242,"Inhibitor of EP300 acetylase activity, decreases tau levels.",2-[(2-hydroxybenzoyl)oxy]benzoic acid,552-94-3,C14H10O5,OC(=O)c1ccccc1OC(=O)c1ccccc1O,"InChI=1S/C14H10O5/c15-11-7-3-1-5-9(11)14(18)19-12-8-4-2-6-10(12)13(16)17/h1-8,15H,(H,16,17)",WVYADZUPLLSGPU-UHFFFAOYSA-N,
CHENDI00058,trichostatin A,pmid:21427723,"Pan-HDAC inhibitor, increases tau acetylation levels.","(2E,4E,6R)-7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienamide",58880-19-6,C17H22N2O3,C[C@@H](C(=O)c1ccc(cc1)N(C)C)\C=C(C)\C=C\C(=O)NO,"InChI=1S/C17H22N2O3/c1-12(5-10-16(20)18-22)11-13(2)17(21)14-6-8-15(9-7-14)19(3)4/h5-11,13,22H,1-4H3,(H,18,20)/b10-5+,12-11+/t13-/m1/s1",RTKIYFITIVXBLE-QEQCGCAPSA-N,
CHENDI00059,vorinostat,pmid:25546293,"Inhibitor of HDAC6 activity, promotes acetylation of beta-catenin at Lys49, which decreases its ubiquitination and induces its membrane localization thus interferring with Wnt signaling. ",N-hydroxy-N'-phenyloctanediamide,149647-78-9	,C14H20N2O3,ONC(=O)CCCCCCC(=O)Nc1ccccc1,"InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18)",WAEXFXRVDQXREF-UHFFFAOYSA-N,
CHENDI00060,ACY-1215,pmid:24844691,"Ricolinostat is an orally bioavailable, specific inhibitor of histone deacetylase 6 (HDAC6) with potential antineoplastic activity. Ricolinostat selectively targets and binds to HDAC6, thereby disrupting the Hsp90 protein chaperone system through hyperacetylation of Hsp90 and preventing the subsequent aggresomal protein degradation. This leads to an accumulation of unfolded and misfolded ubiquitinated proteins and may eventually induce cancer cell apoptosis, and inhibition of cancer cell growth. HDAC6, a class II HDAC deacetylase located in the cytoplasm, appears to play a key role in the formation and activation of the aggresomes needed for degradation of misfolded proteins. Compared to non-selective HDAC inhibitor, ACY-1215 is able to reduce the toxic effects on normal, healthy cells.",N-[7-(hydroxyamino)-7-oxoheptyl]-2-(N-phenylanilino)pyrimidine-5-carboxamide,1316214-52-4,C24H27N5O3,C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO,"InChI=1S/C24H27N5O3/c30-22(28-32)15-9-1-2-10-16-25-23(31)19-17-26-24(27-18-19)29(20-11-5-3-6-12-20)21-13-7-4-8-14-21/h3-8,11-14,17-18,32H,1-2,9-10,15-16H2,(H,25,31)(H,28,30)",QGZYDVAGYRLSKP-UHFFFAOYSA-N,
CHENDI00061,Biphenyl-4-yl-acrylohydroxamoc acids,pmid:26890116,Chemical compund group acting as inhibitors of HDAC family proteins.,,,,,,,
CHENDI00062,C-30-27,pmid:25672970,"PCAF and NFkappaB inhibitor, showed anti-inflammatory properties and improved cognition",,,,,,,
CHENDI00063,C646,pmid:20869593,Inhibitor of EP300 acetylase,"4-[(4Z)-4-[[5-(4,5-dimethyl-2-nitrophenyl)furan-2-yl]methylidene]-3-methyl-5-oxopyrazol-1-yl]benzoic acid",,C24H19N3O6,CC1=C(C=C(C(=C1)C2=CC=C(O2)C=C3C(=NN(C3=O)C4=CC=C(C=C4)C(=O)O)C)[N+](=O)[O-])C,"InChI=1S/C24H19N3O6/c1-13-10-20(21(27(31)32)11-14(13)2)22-9-8-18(33-22)12-19-15(3)25-26(23(19)28)17-6-4-16(5-7-17)24(29)30/h4-12H,1-3H3,(H,29,30)/b19-12-",HEKJYZZSCQBJGB-UNOMPAQXSA-N,
CHENDI00064,CGP3466B,pmid:29559585,"Inhibitor of GAPDH nitrosylation, abrogated Abeta induced tau acetylation and subsequent pathological impairments related to AD","Dibenzo[b,f]oxepin-10-ylmethyl-methyl-prop-2-ynylamine",181296-84-4,C19H17NO,CN(CC#C)CC1=CC2=CC=CC=C2OC3=CC=CC=C31,"InChI=1S/C19H17NO/c1-3-12-20(2)14-16-13-15-8-4-6-10-18(15)21-19-11-7-5-9-17(16)19/h1,4-11,13H,12,14H2,2H3",QLMMOGWZCFQAPU-UHFFFAOYSA-N,
CHENDI00065,CM-414,pmid:27550730,"A dual inhibitor of PDE5 and HDACs, chronic treatment of Tg2576 mice, a well characterized AD mouse model, showed decreased Ab and Tau phsophorylation and inhibition of GSK3B activity.",,,,,,,
CHENDI00066,RGFP966,pmid:28771976,Selective inhibitor of HDAC3,(E)-N-(2-amino-4-fluorophenyl)-3-[1-[(E)-3-phenylprop-2-enyl]pyrazol-4-yl]prop-2-enamide,1396841-57-8,C21H19FN4O,C1=CC=C(C=C1)C=CCN2C=C(C=N2)C=CC(=O)NC3=C(C=C(C=C3)F)N,"InChI=1S/C21H19FN4O/c22-18-9-10-20(19(23)13-18)25-21(27)11-8-17-14-24-26(15-17)12-4-7-16-5-2-1-3-6-16/h1-11,13-15H,12,23H2,(H,25,27)/b7-4+,11-8+",BLVQHYHDYFTPDV-VCABWLAWSA-N,
CHENDI00067,SL-327,pmid:24401760,Inhibitor of MAP2K1/2 kinases activity in murine neuroblastoma cell line N2A and decreases Ab load,α-[Amino[(4-aminophenyl)thio]methylene]-2-(trifluoromethyl)benzeneacetonitrile,305350-87-2,C16H12F3N3S,C1=CC=C(C(=C1)C(=C(N)SC2=CC=C(C=C2)N)C#N)C(F)(F)F,"InChI=1S/C16H12F3N3S/c17-16(18,19)14-4-2-1-3-12(14)13(9-20)15(22)23-11-7-5-10(21)6-8-11/h1-8H,21-22H2/b15-13+",JLOXTZFYJNCPIS-FYWRMAATSA-N,
CHENDI00068,ST7612AA1,pmid:27917100,"A thiol derivative, pan-HDAC inhibitor",S-((S)-7-oxo-6-((R)-5-oxopyrrolidine-2-carboxamido)-7-(phenylamino)heptyl) ethanethioate,1428535-92-5 ,C20H27N3O4S,CC(SCCCCC[C@H](NC([C@@H](CC1)NC1=O)=O)C(NC2=CC=CC=C2)=O)=O,"InChI=1S/C20H27N3O4S/c1-14(24)28-13-7-3-6-10-16(19(26)21-15-8-4-2-5-9-15)23-20(27)17-11-12-18(25)22-17/h2,4-5,8-9,16-17H,3,6-7,10-13H2,1H3,(H,21,26)(H,22,25)(H,23,27)/t16-,17+/m0/s1",QGYPCQAYENIOOF-DLBZAZTESA-N,
CHENDI00069,Trithiocarbonates,pmid:18558669,Chemical compound group of susbtrate competitive selective HDAC6 inhibitors,,,,,,,
CHENDI00070,Tubastatin A,pmid:24844691,Inhibitor of HDAC6 shown to also decrease tau hyperphosphorylation and Ab load,"N-hydroxy-4-[(2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5-yl)methyl]benzamide",1252003-15-8,C20H21N3O2,CN1CCC2=C(C1)C3=CC=CC=C3N2CC4=CC=C(C=C4)C(=O)NO,"InChI=1S/C20H21N3O2/c1-22-11-10-19-17(13-22)16-4-2-3-5-18(16)23(19)12-14-6-8-15(9-7-14)20(24)21-25/h2-9,25H,10-13H2,1H3,(H,21,24)",GOVYBPLHWIEHEJ-UHFFFAOYSA-N,
CHENDI00071,MPT0G211,pmid:29844403,"MPT0G211 is a novel potent, selective HDAC6 inhibitor with IC50 of 0.291 nM, displays >1,000-fold selectivity over other HDAC isoforms; significantly inhibits tau phosphorylation on Ser396, Ser404, and phosphorylated tau (p-tau) aggregation, significantly attenuates apoptosis induced by p-tau, inhibits HDAC6/Hsp90 binding and causes subsequent proteasomal degradation of polyubiquitinated proteins; ameliorates learning and memory impairment in animal models of Alzheimer's disease, reduces the amount of phosphorylated tau in the hippocampal CA1 region; also demonstrates antiproliferative activity against human multiple myeloma RPMI 8226, U266, and NCI-H929 cells with no effect on normal bone marrow cells.",N-hydroxy-4-((quinolin-8-ylamino)methyl)benzamide,2151853-97-1,C17H15N3O2,C1=CC2=C(C(=C1)NCC3=CC=C(C=C3)C(=O)NO)N=CC=C2,"InChI=1S/C17H15N3O2/c21-17(20-22)14-8-6-12(7-9-14)11-19-15-5-1-3-13-4-2-10-18-16(13)15/h1-10,19,22H,11H2,(H,20,21)",BPDQUKCPNSRTTR-UHFFFAOYSA-N,
